Social Capital Suvretta Holdings Corp II (DNAB) 10-Q14 Nov 222022 Q3 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares	9 Months Ended
Cover Page - shares	Sep. 30, 2022	Nov. 14, 2022
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Entity Registrant Name	SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. II
Entity Central Index Key	0001850271
Entity File Number	001-40559
Entity Tax Identification Number	98-1586137
Entity Incorporation, State or Country Code	E9
Entity Address, Address Line One	2850 W. Horizon Ridge Parkway
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Henderson
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89052
City Area Code	650
Local Phone Number	521-9007
Document Quarterly Report	true
Document Transition Report	false
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Shell Company	true
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Title of 12(b) Security	Class A ordinary shares, $0.0001 par value per share
Trading Symbol	DNAB
Security Exchange Name	NASDAQ
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		25,640,000
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		6,250,000

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current Assets
Cash	$ 178,799	$ 435,846
Prepaid expenses	392,375	504,184
Total Current Assets	571,174	940,030
Non-current prepaid insurance	0	247,500
Marketable securities held in Trust Account	251,499,530	250,008,324
TOTAL ASSETS	252,070,704	251,195,854
Current liabilities
Accounts payable and accrued expenses	20,475	86,016
Advances from related party	116,061	10,000
Total current liabilities	136,536	96,016
Deferred underwriting fee payable	7,700,000	7,700,000
Total Liabilities	7,836,536	7,796,016
Commitments and Contingencies (see Note 6)
Temporary Equity
Class A ordinary shares subject to possible redemption, 25,000,000 shares at redemption value as of September 30, 2022 and December 31, 2021	251,499,530	250,008,324
Permanent Deficit
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding as of September 30, 2022 and December 31, 2021	0	0
Additional paid-in capital	0	0
Accumulated deficit	(7,266,051)	(6,609,175)
Total Permanent Deficit	(7,265,362)	(6,608,486)
TOTAL LIABILITIES, TEMPORARY EQUITY AND PERMANENT DEFICIT	252,070,704	251,195,854
Common Class A [Member]
Temporary Equity
Class A ordinary shares subject to possible redemption, 25,000,000 shares at redemption value as of September 30, 2022 and December 31, 2021	251,499,530	250,008,324
Permanent Deficit
Common stock value	64	64
Common Class B [Member]
Permanent Deficit
Common stock value	$ 625	$ 625

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Feb. 24, 2021
Preferred stock par value	$ 0.0001			$ 0.0001
Preferred stock shares authorized	5,000,000			5,000,000
Preferred stock shares issued	0			0
Preferred stock shares outstanding	0			0
Temporary equity shares outstanding	25,000,000	25,000,000	25,000,000	25,000,000	25,000,000	0	0	0
Common Class A [Member]
Common stock par value	$ 0.0001			$ 0.0001
Common stock shares authorized	500,000,000			500,000,000
Common stock shares issued	640,000			640,000
Common stock shares outstanding	640,000			640,000
Temporary equity shares outstanding	25,000,000			25,000,000
Common Class B [Member]
Common stock par value	$ 0.0001			$ 0.0001
Common stock shares authorized	50,000,000			50,000,000
Common stock shares issued	6,250,000			6,250,000
Common stock shares outstanding	6,250,000			6,250,000

Condensed Statements of Operati

Condensed Statements of Operations - USD ($)	3 Months Ended		7 Months Ended	9 Months Ended
Condensed Statements of Operations - USD ($)	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2022
Formation and operational costs	$ 209,569	$ 260,172	$ 265,497	$ 656,876
Loss from operations	(209,569)	(260,172)	(265,497)	(656,876)
Other income:
Interest earned on marketable securities held in Trust Account	1,128,435	3,042	3,042	1,491,206
Net income (loss)	918,866	(257,130)	(262,455)	834,330
Common Class A [Member]
Other income:
Net income (loss)	$ 738,781	$ (206,341)	$ (171,032)	$ 670,813
Weighted average number of shares outstanding, basic	25,640,000	25,358,242	10,884,906	25,640,000
Earnings per share, basic	$ 0.03	$ (0.01)	$ (0.02)	$ 0.03
Weighted average number of shares outstanding, diluted	25,640,000	25,358,242	10,884,906	25,640,000
Earnings per share, diluted	$ 0.03	$ (0.01)	$ (0.02)	$ 0.03
Common Class B [Member]
Other income:
Net income (loss)	$ 180,085	$ (50,789)	$ (91,423)	$ 163,517
Weighted average number of shares outstanding, basic	6,250,000	6,241,758	5,818,396	6,250,000
Earnings per share, basic	$ 0.03	$ (0.01)	$ (0.02)	$ 0.03
Weighted average number of shares outstanding, diluted	6,250,000	6,241,758	5,818,396	6,250,000
Earnings per share, diluted	$ 0.03	$ (0.01)	$ (0.02)	$ 0.03

Condensed Statements of Changes

Condensed Statements of Changes in Temporary Equity and Permanent Deficit - USD ($)	Total	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Common Class A [Member]	Common Class A [Member] Ordinary Shares [Member]	Common Class B [Member]	Common Class B [Member] Ordinary Shares [Member]
Beginning Balance at Feb. 24, 2021	$ 0
Beginning Balance (in shares) at Feb. 24, 2021	0
Beginning Balance at Feb. 24, 2021	$ 0	$ 0	$ 0		$ 0		$ 0
Beginning Balance (in shares) at Feb. 24, 2021							0
Issuance of Class B ordinary shares to Sponsor	25,000	24,367	0				$ 633
Issuance of Class B ordinary shares to Sponsor (in shares)							6,325,000
Net loss	(5,182)		(5,182)
Ending Balance at Mar. 31, 2021	$ 0
Ending Balance (in shares) at Mar. 31, 2021	0
Ending Balance at Mar. 31, 2021	$ 19,818	24,367	(5,182)		$ 0		$ 633
Ending Balance (in shares) at Mar. 31, 2021					0		6,325,000
Beginning Balance at Feb. 24, 2021	$ 0
Beginning Balance (in shares) at Feb. 24, 2021	0
Beginning Balance at Feb. 24, 2021	$ 0	0	0		$ 0		$ 0
Beginning Balance (in shares) at Feb. 24, 2021							0
Net loss	(262,455)			$ (171,032)		$ (91,423)
Ending Balance at Sep. 30, 2021	$ 250,003,042
Ending Balance (in shares) at Sep. 30, 2021	25,000,000
Ending Balance at Sep. 30, 2021	$ (6,320,642)	0	(6,321,331)		$ 64		$ 625
Ending Balance (in shares) at Sep. 30, 2021					640,000		6,250,000
Beginning Balance at Feb. 24, 2021	$ 0
Beginning Balance (in shares) at Feb. 24, 2021	0
Beginning Balance at Feb. 24, 2021	$ 0	0	0		$ 0		$ 0
Beginning Balance (in shares) at Feb. 24, 2021							0
Remeasurement of Class A ordinary shares to redemption value				12,488,469
Ending Balance at Dec. 31, 2021	$ 250,008,324			$ 250,008,324
Ending Balance (in shares) at Dec. 31, 2021	25,000,000			25,000,000
Ending Balance at Dec. 31, 2021	$ (6,608,486)	0	(6,609,175)		$ 64		$ 625
Ending Balance (in shares) at Dec. 31, 2021					640,000		6,250,000
Beginning Balance at Mar. 31, 2021	$ 0
Beginning Balance (in shares) at Mar. 31, 2021	0
Beginning Balance at Mar. 31, 2021	$ 19,818	24,367	(5,182)		$ 0		$ 633
Beginning Balance (in shares) at Mar. 31, 2021					0		6,325,000
Net loss	(143)		(143)
Ending Balance at Jun. 30, 2021	$ 0
Ending Balance (in shares) at Jun. 30, 2021	0
Ending Balance at Jun. 30, 2021	$ 19,675	24,367	(5,325)		$ 0		$ 633
Ending Balance (in shares) at Jun. 30, 2021					0		6,325,000
Sale of 25,000,000 Public Shares, net of underwriting discounts and offering expenses	$ 237,519,855
Sale of 25,000,000 Public Shares, net of underwriting discounts and offering expenses (in shares)	25,000,000
Sale of 640,000 Private Placement Shares	$ 6,400,000	6,399,936			$ 64
Sale of 640,000 Private Placement Shares (in shares)					640,000
Remeasurement of Class A ordinary shares to redemption value	12,483,187
Remeasurement of Class A ordinary shares to redemption value	(12,483,187)	(6,424,311)	(6,058,876)
Forfeiture of Founder Shares		8					$ (8)
Forfeiture of Founder Shares (in shares)							(75,000)
Net loss	(257,130)		(257,130)	$ (206,341)		(50,789)
Ending Balance at Sep. 30, 2021	$ 250,003,042
Ending Balance (in shares) at Sep. 30, 2021	25,000,000
Ending Balance at Sep. 30, 2021	$ (6,320,642)	0	(6,321,331)		$ 64		$ 625
Ending Balance (in shares) at Sep. 30, 2021					640,000		6,250,000
Beginning Balance at Dec. 31, 2021	$ 250,008,324			$ 250,008,324
Beginning Balance (in shares) at Dec. 31, 2021	25,000,000			25,000,000
Beginning Balance at Dec. 31, 2021	$ (6,608,486)	0	(6,609,175)		$ 64		$ 625
Beginning Balance (in shares) at Dec. 31, 2021					640,000		6,250,000
Remeasurement of Class A ordinary shares to redemption value	(8,324)			$ (8,324)
Remeasurement of Class A ordinary shares to redemption value	8,324	0	8,324
Net loss	(206,990)		(206,990)
Ending Balance at Mar. 31, 2022	$ 250,000,000			250,000,000
Ending Balance (in shares) at Mar. 31, 2022	25,000,000
Ending Balance at Mar. 31, 2022	$ (6,807,152)	0	(6,807,841)		$ 64		$ 625
Ending Balance (in shares) at Mar. 31, 2022					640,000		6,250,000
Beginning Balance at Dec. 31, 2021	$ 250,008,324			$ 250,008,324
Beginning Balance (in shares) at Dec. 31, 2021	25,000,000			25,000,000
Beginning Balance at Dec. 31, 2021	$ (6,608,486)	0	(6,609,175)		$ 64		$ 625
Beginning Balance (in shares) at Dec. 31, 2021					640,000		6,250,000
Remeasurement of Class A ordinary shares to redemption value	(1,491,206)
Net loss	834,330			$ 670,813		163,517
Ending Balance at Sep. 30, 2022	$ 251,499,530			$ 251,499,530
Ending Balance (in shares) at Sep. 30, 2022	25,000,000			25,000,000
Ending Balance at Sep. 30, 2022	$ (7,265,362)	0	(7,266,051)		$ 64		$ 625
Ending Balance (in shares) at Sep. 30, 2022					640,000		6,250,000
Beginning Balance at Mar. 31, 2022	$ 250,000,000			$ 250,000,000
Beginning Balance (in shares) at Mar. 31, 2022	25,000,000
Beginning Balance at Mar. 31, 2022	$ (6,807,152)	0	(6,807,841)		$ 64		$ 625
Beginning Balance (in shares) at Mar. 31, 2022					640,000		6,250,000
Remeasurement of Class A ordinary shares to redemption value	371,095			371,095
Remeasurement of Class A ordinary shares to redemption value	(371,095)	0	(371,095)
Net loss	122,454		122,454
Ending Balance at Jun. 30, 2022	$ 250,371,095			250,371,095
Ending Balance (in shares) at Jun. 30, 2022	25,000,000
Ending Balance at Jun. 30, 2022	$ (7,055,793)	0	(7,056,482)		$ 64		$ 625
Ending Balance (in shares) at Jun. 30, 2022					640,000		6,250,000
Remeasurement of Class A ordinary shares to redemption value	1,128,435			1,128,435
Remeasurement of Class A ordinary shares to redemption value	(1,128,435)		(1,128,435)
Net loss	918,866		918,866	738,781		$ 180,085
Ending Balance at Sep. 30, 2022	$ 251,499,530			$ 251,499,530
Ending Balance (in shares) at Sep. 30, 2022	25,000,000			25,000,000
Ending Balance at Sep. 30, 2022	$ (7,265,362)	$ 0	$ (7,266,051)		$ 64		$ 625
Ending Balance (in shares) at Sep. 30, 2022					640,000		6,250,000

Statements of Changes in Tempor

Statements of Changes in Temporary Equity and Permanent Equity (Deficit) (Parenthetical)	3 Months Ended
	Sep. 30, 2021 USD ($) shares
Temporary Equity Stock Issued During The Period Shares \| shares	25,000,000
Proceeds from private placement issue \| $	$ 640,000

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows - USD ($)	3 Months Ended		7 Months Ended	9 Months Ended
Condensed Statements of Cash Flows - USD ($)	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2022
Cash Flows from Operating Activities:
Net income (loss)	$ 918,866	$ (257,130)	$ (262,455)	$ 834,330
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Formation costs paid by Sponsor in exchange for issuance of Founder Shares			5,000	0
Interest earned on marketable securities held in Trust Account	(1,128,435)	(3,042)	(3,042)	(1,491,206)
Changes in operating assets and liabilities:
Prepaid expenses			(899,811)	111,809
Non-current prepaid insurance				247,500
Advances from related party				106,061
Accounts payable and accrued expenses			17,008	(65,541)
Net cash used in operating activities			(1,143,300)	(257,047)
Cash Flows from Investing Activities:
Investment of cash in Trust Account			(250,000,000)
Net cash used in investing activities			(250,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Public Shares, net of underwriting discounts paid			245,600,000
Proceeds from sale of Private Placement Shares		640,000	6,400,000
Advances from related party			63,899
Repayment of advances from related party			(25,692)
Proceeds from promissory note – related party			300,000	0
Repayment of promissory note – related party			(300,000)
Payment of offering costs			(360,145)	0
Net cash provided by financing activities			251,678,062	0
Net Change in Cash			534,762	(257,047)
Cash – Beginning of Period				435,846
Cash – End of Period	178,799	534,762	534,762	178,799
Non-Cash Investing and Financing Activities:
Offering costs paid by Sponsor in exchange for issuance of founder shares			20,000	0
Deferred underwriting fee payable		7,700,000	$ 7,700,000
Remeasurement of Class A ordinary share subject to possible redemption	$ 1,128,435	$ 12,483,187		$ 1,491,206

Description Of Organization, Bu

Description Of Organization, Business Operations And Going Concern	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description Of Organization, Business Operations And Going Concern	NOTE 1. DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN Social Capital Suvretta Holdings Corp. II (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on February 25, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2022, the Company had not commenced any operations. All activity for the period from February 25, 2021 (inception) through September 30, 2022 relates to the Company’s formation, the initial public offering (the “Initial Public Offering”), described below, and, subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating The registration statements for the Company’s Initial Public Offering became effective on June 29, 2021 and June 30, 2021. On July 2, 2021, the Company consummated the Initial Public Offering of 25,000,000 Class A ordinary shares (the “Public Shares”), which includes the partial exercise by the underwriters of their over-allotment option in the amount of 3,000,000 Public Shares, at $10.00 per Public Share, generating gross proceeds of $250,000,000, which is described in Note 3. The fair value attributable to the unexercised portion of the over-allotment option was deemed to be immaterial to the condensed financial statements. Concurrently with the closing of the Initial Public Offering, the Company consummated the sale of 640,000 Class A ordinary shares (the “Private Placement Shares”) at a price of $10.00 per Private Placement Share in a private placement to SCS Sponsor II LLC, a Cayman Islands limited liability company (the “Sponsor”), generating gross proceeds of $6,400,000, which is described in Note 4. Transaction costs amounted to $12,480,145, consisting of $4,400,000 of underwriting fees, $7,700,000 of deferred underwriting fees and $380,145 of other offering costs. In connection with the closing of the Initial Public Offering on July 2, 2021, an amount of $250,000,000 ($10.00 per Public Share) from the net proceeds of the sale of the Public Shares in the Initial Public Offering and the sale of the Private Placement Shares was placed in a trust account (the “Trust Account”), and invested in U.S. government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries and meeting certain conditions of Rule 2a-7 pre-Business The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Shares, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company must complete one or more Business Combinations having an aggregate fair market value of at least 80% of the value of the assets held in the Trust Account (excluding any deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the Company signing a definitive agreement in connection with the Business Combination. However, the Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company will provide the Public Shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of the Business Combination, either (a) in connection with a general meeting called to approve the Business Combination or (b) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem all or a portion of their Public Shares at a per-share In accordance with the Company’s Amended and Restated Memorandum and Articles of Association, in no event will the Company redeem the Public Shares in an amount that would cause the Company’s net tangible assets to be less than $5,000,001 following such redemptions. Redemptions of the Public Shares may also be subject to a higher net tangible asset test or cash requirement pursuant to an agreement relating to the Business Combination. If a shareholder vote is not required in connection with a Business Combination and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by applicable law or stock exchange listing requirement, or the Company decides to obtain shareholder approval for business or other reasons, the Company will conduct the redemptions in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules and will file proxy materials with the SEC. If the Company seeks shareholder approval in connection with a Business Combination, the Company will complete such Business Combination only if the Company receives an ordinary resolution under Cayman Islands law, which requires the affirmative vote of holders of a majority of ordinary shares who attend and vote at a general meeting of the Company. The Public Shareholders may elect to redeem their Public Shares without voting and, if they do vote, irrespective of whether they vote for or against a Business Combination. Notwithstanding the foregoing redemption rights, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its Public Shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent. The Sponsor and the Company’s directors and officers have agreed to waive: (a) their redemption rights with respect to any Founder Shares, Private Placement Shares and Public Shares held by them, as applicable, in connection with the completion of a Business Combination; (b) their redemption rights with respect to any Founder Shares, Private Placement Shares and Public Shares held by them in connection with a shareholder vote to amend the Company’s Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period, or (ii) with respect to any other material provisions relating to shareholders’ rights or pre-Business The Company will have until July 2, 2023 to complete a Business Combination (the “Combination Period”), or such longer period as a result of a shareholder vote to amend such time period pursuant to the Company’s Amended and Restated Memorandum and Articles of Association. However, if the Company has not completed a Business Combination within such Combination Period or during any applicable extension period, the Company will: (a) cease all operations except for the purpose of winding up; (b) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at per-share The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party that executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company has not independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believes that the Sponsor’s only assets are securities of the Company and, therefore, the Sponsor may not be able to satisfy those obligations. The Company has not asked the Sponsor to reserve for such obligations. None of the Company’s directors or officers will indemnify the Company for claims by third parties, including, without limitation, claims by vendors and prospective target businesses. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 Liquidity, Capital Resources and Going Concern As of September 30, 2022, the Company had $178,799 in its operating bank account and working capital of $434,638. Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. The Company may need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15,

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
Summary of Significant Accounting Policies	Sep. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q S-X The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements contained in the Company’s Annual Report on Form 10-K Form 10-K. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of the condensed financial statements in conformity with GAAP requires the management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Significant accounting estimates include the determination of the fair value of Class A ordinary shares subject to possible redemption and the fair value of Founder Shares transferred to directors. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2022 and December 31, 2021. Marketable Securities Held in Trust Account At September 30, 2022 and December 31, 2021, substantially all of the assets held in the Trust Account were held in a money market fund which is invested primarily in U.S. Treasury securities. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at redemption value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as permanent deficit. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the permanent deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying value of redeemable ordinary shares are affected by charges against additional paid-in At September 30, 2022 and December 31, 2021, the Class A ordinary shares subject to possible redemption reflected in the condensed balance sheets are reconciled in the following table: Gross proceeds $ 250,000,000 Less: Class A ordinary shares issuance costs (12,480,145 ) Plus: Accretion of carrying value to redemption value 12,488,469 Class A ordinary shares subject to redemption, December 31, 2021 250,008,324 Less: Remeasurement of carrying value to redemption value (8,324 ) Class A ordinary shares subject to redemption, March 31, 2022 250,000,000 Plus: Remeasurement of carrying value to redemption value 371,095 Class A ordinary shares subject to redemption, June 30, 2022 250,371,095 Plus: Remeasurement of carrying value to redemption value 1,128,435 Class A ordinary shares subject to possible redemption, September 30, 2022 $ 251,499,530 Offering Costs The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs paid-in Share-Based Payment Arrangements The Company accounts for stock awards in accordance with ASC 718, “Compensation—Stock Compensation,” which requires that all equity awards be accounted for at their “fair value.” Fair value is measured on the grant date and is equal to the underlying value of the stock. Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, in the period of grant for awards that vest immediately and have no future service condition, or in the period the awards vest immediately after meeting a performance condition becomes probable (i.e., the occurrence of a Business Combination). For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from the Company’s initial estimates; previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited. Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the condensed financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s condensed financial statements and prescribes a recognition threshold and measurement process for condensed financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not The Company is considered to be an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. Net Income (Loss) per Ordinary Share Net income (loss) per ordinary share is computed by dividing net income by the weighted-average number of ordinary shares outstanding during the period. The Company has two classes of ordinary shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income (Loss) are shared pro rata between the two classes of shares. Remeasurement associated with the redeemable Class A ordinary shares are excluded from net income (loss) per ordinary share as the redemption value approximates fair value. As of September 30, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the periods presented. The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): Three Months Ended September 30, Nine Months Ended For the Period from 2022 2021 Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share Numerator: Allocation of net income (loss) $ 738,781 $ 180,085 $ (206,341 ) $ (50,789 ) $ 670,813 $ 163,517 $ (171,032 ) $ (91,423 ) Denominator: Basic and diluted weighted average shares outstanding 25,640,000 6,250,000 25,358,242 6,241,758 25,640,000 6,250,000 10,884,906 5,818,396 Basic and diluted net income (loss) per ordinary share $ 0.03 $ 0.03 $ (0.01 ) $ (0.01 ) $ 0.03 $ 0.03 $ (0.02 ) $ (0.02 ) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement” (“ASC 820”), approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.

Initial Public Offering

Initial Public Offering	9 Months Ended
Initial Public Offering	Sep. 30, 2022
Equity [Abstract]
Initial Public Offering	NOTE 3. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 25,000,000 Public Shares, which includes a partial exercise by the underwriters of their over-allotment option in the amount of 3,000,000 Public Shares, at a price of $10.00 per Public Share. Unlike some other initial public offerings of special purpose acquisition companies, investors in the Initial Public Offering did not receive any warrants (which would typically become exercisable following completion of the Business Combination). The fair value attributable to the unexercised portion of the over-allotment option was deemed to be immaterial to the condensed financial statements.

Private Placement

Private Placement	9 Months Ended
Private Placement	Sep. 30, 2022
Private Placement [Abstract]
Private Placement	NOTE 4. PRIVATE PLACEMENT Substantially concurrently with the closing of the Initial Public Offering, the Sponsor purchased 640,000 Private Placement Shares at a price of $10.00 per Private Placement Share, for an aggregate purchase price of $6,400,000. Each Private Placement Share is identical to the Class A ordinary shares sold in the Initial Public Offering, subject to certain limited exceptions as described in Note 7. A portion of the proceeds from the sale of the Private Placement Shares was added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period or during any applicable extension period, the proceeds from the sale of the Private Placement Shares held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Shares will be worthless.

Related Party Transactions

Related Party Transactions	9 Months Ended
Related Party Transactions	Sep. 30, 2022
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On March 2, 2021, the Sponsor paid $25,000 to cover certain offering and formation costs of the Company in consideration for which the Sponsor received 5,750,000 Class B ordinary shares (the “Founder Shares”). On June 29, 2021, the Company effected a share capitalization with respect to its Class B ordinary shares of 575,000 shares thereof, resulting in the Company’s initial shareholders holding an aggregate of 6,325,000 Founder Shares. All share and per-share In June 2021, the Sponsor transferred 30,000 Founder Shares to Sapna Srivastava, an independent director of the Company. The sale of the Founders Shares to the Company’s director is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The fair value of the 30,000 shares granted to the Company’s director was $214,160 or approximately $7.14 per share. The Founders Shares were effectively sold subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the Founders Shares is recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance. As of September 30, 2022, the Company determined that a Business Combination is not considered probable, and, therefore, no stock-based compensation expense has been recognized. Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in an amount equal to the number of Founders Shares times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares. The Sponsor and the Company’s directors and officers have agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, 30-trading Administrative Services Agreement The Company entered into an agreement in which it will pay an affiliate of the Sponsor $10,000 per month, commencing on June 30, 2021, for office space, administrative and support services. Upon completion of a Business Combination or its liquidation, the Company will cease paying these monthly fees. For the three months and nine months ended September 30, 2022, the Company incurred $30,000 and $90,000, respectively, of which such fee is included in Advances from Related Party in the accompanying condensed balance sheets. For the period from February 25, 2021 (inception) through September 30, 2021, the Company incurred $30,000 in fees for these services. Advances from Related Party For the nine months ended September 30, 2022, an affiliate of the Sponsor had advanced the Company $106,061 for working capital purposes, of which $0 was repaid during the three months and nine months ended September 30, 2022. As of September 30, 2022 and December 31, 2021, the outstanding balance under the advances amounted to $116,061 and $10,000, respectively. Promissory Note — Related Party On March 2, 2021, the Company issued an unsecured promissory note to the Sponsor (the “Pre-IPO Pre-IPO Pre-IPO Pre-IPO Related Party Loans In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, it may repay such loaned amounts out of the proceeds of the Trust Account. In the event that the Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used to repay such loaned amounts. As of September 30, 2022 and December 31, 2021, there were no amounts outstanding under the Working Capital Loans.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 6. COMMITMENTS AND CONTINGENCIES Registration Rights Pursuant to a registration rights agreement entered into on June 29, 2021, the holders of the Founder Shares, Private Placement Shares and any Private Placement Shares that may be issued on conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the conversion of the Founder Shares) are entitled to registration rights requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to the Class A ordinary shares). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters are entitled to a deferred underwriting commission of $7,700,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Restricted Stock Unit Award In June 2022, pursuant to a Director Restricted Stock Unit Award Agreement, dated June 29, 2022, between the Company and Dr. Berman, the Company agreed to grant 30,000 restricted stock units (“RSUs”) to Dr. Berman, which grant is contingent on both the consummation of a Business Combination and a shareholder approved equity plan. The RSUs will vest upon the consummation of such Business Combination and represent 30,000 Class A ordinary shares (or, following a domestication by the Company as a Delaware corporation, shares of common stock) of the Company that will settle on a date determined in the sole discretion of the Company that shall occur between the vesting date and March 15 of the year following the year in which vesting occurs. In September 2021, pursuant to a Director Restricted Stock Unit Award Agreement, dated September 24, 2021, between the Company and Sean P. Nolan, the Company agreed to grant 30,000 RSUs to Mr. Nolan, which grant is contingent on both the consummation of a Business Combination and a shareholder approved equity plan. These RSUs will vest upon the consummation of such Business Combination and represent 30,000 Class A ordinary shares of the Company that will settle on a date determined in the sole discretion of the Company that shall occur between the vesting date and March 15 of the year following the year in which vesting occurs. The RSUs to be granted by the Company are in the scope of ASC 718. Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The RSUs to be granted are subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the RSUs is recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance. As of September 30, 2022, the Company did not have a shareholder approved equity plan and also determined that a Business Combination is not considered probable, and, therefore, no stock-based compensation expense has been recognized. Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) and once a shareholder equity plan is approved in an amount equal to the number of RSUs times the grant date fair value per share (unless subsequently modified).

Temporary Equity And Permanent

Temporary Equity And Permanent Deficit	9 Months Ended
Temporary Equity And Permanent Deficit	Sep. 30, 2022
Stockholders' Equity Note [Abstract]
Temporary Equity And Permanent Deficit	NOTE 7. TEMPORARY EQUITY AND PERMANENT DEFICIT Preference Shares — Class A Ordinary Shares Class B Ordinary Shares Holders of record of Class A ordinary shares and Class B ordinary shares are entitled to one vote for each share held on all matters to be voted on by shareholders and vote together as a single class, except as required by law; provided that prior to a Business Combination, holders of Class B ordinary shares will have the right to appoint all of the Company’s directors and remove members of its board of directors for any reason, and holders of Class A ordinary shares will not be entitled to vote on the appointment of directors during such time. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the Business Combination, or earlier at the option of the holder, on a one-for-one sub-divisions, one-for-one Private Placement Shares

Fair Value Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	NOTE 8. FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured non-financial are re-measured The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2022 and December 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level September 30, 2022 December 31, 2021 Assets: Marketable securities held in Trust Account 1 $ 251,499,530 $ 250,008,324

Subsequent Events

Subsequent Events	9 Months Ended
Subsequent Events	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	NOTE 9. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
Summary of Significant Accounting Policies (Policies)	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q S-X The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements contained in the Company’s Annual Report on Form 10-K Form 10-K.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
Use of Estimates	Use of Estimates The preparation of the condensed financial statements in conformity with GAAP requires the management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Significant accounting estimates include the determination of the fair value of Class A ordinary shares subject to possible redemption and the fair value of Founder Shares transferred to directors. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2022 and December 31, 2021.
Marketable Securities Held in Trust Account	Marketable Securities Held in Trust Account At September 30, 2022 and December 31, 2021, substantially all of the assets held in the Trust Account were held in a money market fund which is invested primarily in U.S. Treasury securities.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at redemption value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as permanent deficit. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the permanent deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying value of redeemable ordinary shares are affected by charges against additional paid-in At September 30, 2022 and December 31, 2021, the Class A ordinary shares subject to possible redemption reflected in the condensed balance sheets are reconciled in the following table: Gross proceeds $ 250,000,000 Less: Class A ordinary shares issuance costs (12,480,145 ) Plus: Accretion of carrying value to redemption value 12,488,469 Class A ordinary shares subject to redemption, December 31, 2021 250,008,324 Less: Remeasurement of carrying value to redemption value (8,324 ) Class A ordinary shares subject to redemption, March 31, 2022 250,000,000 Plus: Remeasurement of carrying value to redemption value 371,095 Class A ordinary shares subject to redemption, June 30, 2022 250,371,095 Plus: Remeasurement of carrying value to redemption value 1,128,435 Class A ordinary shares subject to possible redemption, September 30, 2022 $ 251,499,530
Offering Cost	Offering Costs The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs paid-in
Share-Based Payment Arrangements	Share-Based Payment Arrangements The Company accounts for stock awards in accordance with ASC 718, “Compensation—Stock Compensation,” which requires that all equity awards be accounted for at their “fair value.” Fair value is measured on the grant date and is equal to the underlying value of the stock. Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, in the period of grant for awards that vest immediately and have no future service condition, or in the period the awards vest immediately after meeting a performance condition becomes probable (i.e., the occurrence of a Business Combination). For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from the Company’s initial estimates; previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited.
Income Taxes	Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the condensed financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s condensed financial statements and prescribes a recognition threshold and measurement process for condensed financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not The Company is considered to be an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.
Net Income (Loss) per Ordinary Share	Net Income (Loss) per Ordinary Share Net income (loss) per ordinary share is computed by dividing net income by the weighted-average number of ordinary shares outstanding during the period. The Company has two classes of ordinary shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income (Loss) are shared pro rata between the two classes of shares. Remeasurement associated with the redeemable Class A ordinary shares are excluded from net income (loss) per ordinary share as the redemption value approximates fair value. As of September 30, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the periods presented. The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): Three Months Ended September 30, Nine Months Ended For the Period from 2022 2021 Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share Numerator: Allocation of net income (loss) $ 738,781 $ 180,085 $ (206,341 ) $ (50,789 ) $ 670,813 $ 163,517 $ (171,032 ) $ (91,423 ) Denominator: Basic and diluted weighted average shares outstanding 25,640,000 6,250,000 25,358,242 6,241,758 25,640,000 6,250,000 10,884,906 5,818,396 Basic and diluted net income (loss) per ordinary share $ 0.03 $ 0.03 $ (0.01 ) $ (0.01 ) $ 0.03 $ 0.03 $ (0.02 ) $ (0.02 )
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement” (“ASC 820”), approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.
Recent Accounting Standards	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
Summary of Significant Accounting Policies (Tables)	Sep. 30, 2022
Accounting Policies [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): Three Months Ended September 30, Nine Months Ended For the Period from 2022 2021 Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share Numerator: Allocation of net income (loss) $ 738,781 $ 180,085 $ (206,341 ) $ (50,789 ) $ 670,813 $ 163,517 $ (171,032 ) $ (91,423 ) Denominator: Basic and diluted weighted average shares outstanding 25,640,000 6,250,000 25,358,242 6,241,758 25,640,000 6,250,000 10,884,906 5,818,396 Basic and diluted net income (loss) per ordinary share $ 0.03 $ 0.03 $ (0.01 ) $ (0.01 ) $ 0.03 $ 0.03 $ (0.02 ) $ (0.02 )
Summary of Class A ordinary shares subject to possible redemption	At September 30, 2022 and December 31, 2021, the Class A ordinary shares subject to possible redemption reflected in the condensed balance sheets are reconciled in the following table: Gross proceeds $ 250,000,000 Less: Class A ordinary shares issuance costs (12,480,145 ) Plus: Accretion of carrying value to redemption value 12,488,469 Class A ordinary shares subject to redemption, December 31, 2021 250,008,324 Less: Remeasurement of carrying value to redemption value (8,324 ) Class A ordinary shares subject to redemption, March 31, 2022 250,000,000 Plus: Remeasurement of carrying value to redemption value 371,095 Class A ordinary shares subject to redemption, June 30, 2022 250,371,095 Plus: Remeasurement of carrying value to redemption value 1,128,435 Class A ordinary shares subject to possible redemption, September 30, 2022 $ 251,499,530

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Summary of Fair Value Measurements, Recurring and Nonrecurring	The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2022 and December 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level September 30, 2022 December 31, 2021 Assets: Marketable securities held in Trust Account 1 $ 251,499,530 $ 250,008,324

Description Of Organization, _2

Description Of Organization, Business Operations And Going Concern - Additional Information (Detail) - USD ($)		3 Months Ended	7 Months Ended	9 Months Ended	10 Months Ended
	Jul. 02, 2021	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2022	Dec. 31, 2021
Description Of Organization And Business Operations [Line Items]
Incorporation date of entity				Feb. 25, 2021
Proceeds from initial public offering			$ 245,600,000
Proceeds from private placement issue		$ 640,000	$ 6,400,000
Deferred underwriting fee				$ 7,700,000
Minimum net worth to consummate business combination				$ 5,000,001
Percentage of public shares that can be transferred without any restriction				15%
Percentage of public shares to be redeemed in case business combination is not consummated				100%
Interest to pay dissolution expenses				$ 100,000
Per share value of restricted assets				$ 10
Percentage of public shares redemption	100%
Cash				$ 178,799	$ 435,846
Working Capital				$ 434,638
Minimum [Member]
Description Of Organization And Business Operations [Line Items]
Prospective assets of acquire as a percentage of fair value of assets in the trust account				80%
Minimum [Member] \| Investment In Nonconsolidated Investees, Other [Member]
Description Of Organization And Business Operations [Line Items]
Equity method investment ownership percentage				50%
Common Class A [Member]
Description Of Organization And Business Operations [Line Items]
Proceeds from initial public offering					$ 250,000,000
Common Class A [Member] \| IPO [Member]
Description Of Organization And Business Operations [Line Items]
Stock issued during period new shares issued	25,000,000
Sale of stock price per share	$ 10
Proceeds from initial public offering	$ 250,000,000
Transaction costs incurred in connection with initial public offering				$ 12,480,145
Underwriting fee				4,400,000
Deferred underwriting fee				7,700,000
Deferred offering costs				$ 380,145
Common stock held in trust account	$ 250,000,000
Common Class A [Member] \| Over-Allotment Option [Member]
Description Of Organization And Business Operations [Line Items]
Stock issued during period new shares issued	3,000,000
Common Class A [Member] \| Private Placement [Member]
Description Of Organization And Business Operations [Line Items]
Stock issued during period new shares issued	640,000
Sale of stock price per share	$ 10
Proceeds from private placement issue	$ 6,400,000

Summary of Significant Accoun_4

Summary of Significant Accounting - Schedule of Earnings Per Share, Basic and Diluted (Detail) Policies - USD ($)	1 Months Ended	3 Months Ended					7 Months Ended	9 Months Ended
	Mar. 31, 2021	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Sep. 30, 2021	Sep. 30, 2022
Earnings Per Share Basic And Diluted [Line Items]
Allocation of net loss	$ (5,182)	$ 918,866	$ 122,454	$ (206,990)	$ (257,130)	$ (143)	$ (262,455)	$ 834,330
Common Class A [Member]
Earnings Per Share Basic And Diluted [Line Items]
Allocation of net loss		$ 738,781			$ (206,341)		$ (171,032)	$ 670,813
Weighted average number of shares outstanding, basic		25,640,000			25,358,242		10,884,906	25,640,000
Earnings per share, basic		$ 0.03			$ (0.01)		$ (0.02)	$ 0.03
Weighted average number of shares outstanding, diluted		25,640,000			25,358,242		10,884,906	25,640,000
Earnings per share, diluted		$ 0.03			$ (0.01)		$ (0.02)	$ 0.03
Common Class B [Member]
Earnings Per Share Basic And Diluted [Line Items]
Allocation of net loss		$ 180,085			$ (50,789)		$ (91,423)	$ 163,517
Weighted average number of shares outstanding, basic		6,250,000			6,241,758		5,818,396	6,250,000
Earnings per share, basic		$ 0.03			$ (0.01)		$ (0.02)	$ 0.03
Weighted average number of shares outstanding, diluted		6,250,000			6,241,758		5,818,396	6,250,000
Earnings per share, diluted		$ 0.03			$ (0.01)		$ (0.02)	$ 0.03

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2022 USD ($)
Accounting Policies [Line Items]
Cash, FDIC Insured Amount	$ 250,000
Common Class A [Member] \| IPO [Member]
Accounting Policies [Line Items]
Transaction costs incurred in connection with initial public offering	12,480,145
Deferred offering costs	380,145
Underwriting fee	4,400,000
Deferred underwriting fee	$ 7,700,000

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Summary of Class A ordinary shares subject to possible redemption (Detail) - USD ($)	3 Months Ended				7 Months Ended	10 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Sep. 30, 2021	Dec. 31, 2021	Jun. 30, 2021	Mar. 31, 2021	Feb. 24, 2021
Temporary Equity [Line Items]
Gross proceeds					$ 245,600,000
Accretion of carrying value to redemption value	$ 1,128,435	$ 371,095	$ (8,324)	$ 12,483,187
Class A ordinary shares subject to possible redemption	251,499,530	250,371,095	250,000,000	$ 250,003,042	$ 250,003,042	$ 250,008,324	$ 0	$ 0	$ 0
Common Class A [Member]
Temporary Equity [Line Items]
Gross proceeds						250,000,000
Class A ordinary shares issuance costs						(12,480,145)
Accretion of carrying value to redemption value	1,128,435	371,095	(8,324)			12,488,469
Class A ordinary shares subject to possible redemption	$ 251,499,530	$ 250,371,095	$ 250,000,000			$ 250,008,324

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Detail) - Common Class A [Member]	Jul. 02, 2021 $ / shares shares
IPO [Member]
Class of Stock [Line Items]
Stock issued during period new shares issued	25,000,000
Sale of stock price per share \| $ / shares	$ 10
Over-Allotment Option [Member]
Class of Stock [Line Items]
Stock issued during period new shares issued	3,000,000

Private Placement - Additional

Private Placement - Additional Information (Detail) - USD ($)		3 Months Ended	7 Months Ended
	Jul. 02, 2021	Sep. 30, 2021	Sep. 30, 2021
Class of Stock [Line Items]
Proceeds from private placement issue		$ 640,000	$ 6,400,000
Common Class A [Member] \| Private Placement [Member]
Class of Stock [Line Items]
Stock issued during period new shares issued	640,000
Sale of stock price per share	$ 10
Proceeds from private placement issue	$ 6,400,000

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)					1 Months Ended	3 Months Ended		6 Months Ended	7 Months Ended	9 Months Ended
	Jul. 02, 2021	Jun. 30, 2021	Jun. 29, 2021	Mar. 02, 2021	Mar. 31, 2021	Sep. 30, 2022	Jun. 30, 2022	Jun. 30, 2021	Sep. 30, 2021	Sep. 30, 2022	Dec. 31, 2021
Related Party Transaction [Line Items]
Stock shares issued during the period for services value					$ 25,000
Repayments of Related Party Debt									$ 25,692
Stock based compensation expense										$ 0
Director [Member]
Related Party Transaction [Line Items]
Share price		$ 7.14						$ 7.14
Number of shares granted		30,000
Fair value of shares granted		$ 214,160
Founder [Member]
Related Party Transaction [Line Items]
Stock Issued During Period, Shares, New Issues								30,000
Common Class B [Member]
Related Party Transaction [Line Items]
Common stock shares outstanding						6,250,000				6,250,000	6,250,000
Shares no longer subject to forfeiture						750,000				750,000
Common Class B [Member] \| Founder [Member]
Related Party Transaction [Line Items]
Stock shares issued during the period for services value				$ 25,000
Stock shares issued during the period for services shares				5,750,000
Stock Issued During Period, Shares, New Issues			575,000
Common stock shares outstanding			6,325,000
Common Stock, Shares, Subject to Forfeiture						825,000				825,000
Share based compensation shares forfeited during the period										75,000
Administration And Support Services [Member] \| Sponsor [Member]
Related Party Transaction [Line Items]
Related party transaction fees payable per month										$ 10,000
Selling general and administrative expenses from transactions with related party						$ 30,000	$ 30,000			90,000
Advance From Related Party Loan [Member]
Related Party Transaction [Line Items]
Due to Related Parties						116,061				116,061	$ 10,000
Advance From Related Party Loan [Member] \| Sponsor [Member]
Related Party Transaction [Line Items]
Due to Related Parties						106,061				106,061
Repayment of advances from related party										0
Promissory Note [Member] \| Sponsor [Member]
Related Party Transaction [Line Items]
Repayments of Related Party Debt	$ 300,000
Debt instrument face value				$ 300,000
Working Capital Loans [Member] \| Sponsor [Member]
Related Party Transaction [Line Items]
Due to Related Parties						$ 0				$ 0	$ 0
Restriction On Transfer Of Sponsor Shares [Member] \| Common Class B [Member] \| Founder [Member]
Related Party Transaction [Line Items]
Lock in period of shares										1 year
Share price						$ 12				$ 12
Number of trading days for determining the share price										20 days
Number of consecutive trading days for determining the share price										30 days
Waiting period after which the share trading days are considered										150 days

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($)		9 Months Ended
	Sep. 24, 2021	Sep. 30, 2022
Loss Contingencies [Line Items]
Deferred Underwriting Fees		$ 7,700,000
Director Restricted Stock Unit Award Agreement [Member] \| Common Class A [Member]
Loss Contingencies [Line Items]
Number of shares of common stock committed to settle on a date following the year Business combination occurs	30,000	30,000
Director Restricted Stock Unit Award Agreement [Member] \| Restricted Stock Units (RSUs) [Member]
Loss Contingencies [Line Items]
Number of stock units granted	30,000	30,000

Temporary Equity And Permanen_2

Temporary Equity And Permanent Deficit - Additional Information (Detail) - $ / shares	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Feb. 24, 2021
Class of Stock [Line Items]
Preferred stock shares authorized	5,000,000			5,000,000
Preferred stock par value	$ 0.0001			$ 0.0001
Preferred stock shares issued	0			0
Preferred stock shares outstanding	0			0
Temporary equity shares outstanding	25,000,000	25,000,000	25,000,000	25,000,000	25,000,000	0	0	0
Common Class A [Member]
Class of Stock [Line Items]
Common stock shares authorized	500,000,000			500,000,000
Common stock par value	$ 0.0001			$ 0.0001
Common stock shares issued	640,000			640,000
Common stock shares outstanding	640,000			640,000
Temporary equity shares outstanding	25,000,000			25,000,000
Common Class B [Member]
Class of Stock [Line Items]
Common stock shares authorized	50,000,000			50,000,000
Common stock par value	$ 0.0001			$ 0.0001
Common stock shares issued	6,250,000			6,250,000
Common stock shares outstanding	6,250,000			6,250,000
Percent of founders shares to Company's issued and outstanding ordinary shares	20%			20%

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Fair Value Measurements, Recurring and Nonrecurring (Detail) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Fair Value, Recurring [Member] \| Fair Value, Inputs, Level 1 [Member] \| Marketable Securities Held In Trust Account [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	$ 251,499,530	$ 250,008,324